This brand name is authorized in Estonia, Lithuania, Poland, Singapore
The drug DRYTEC contains one active pharmaceutical ingredient (API):
|
1
Technetium ⁹⁹ᵐTc pertechnetate
UNII 7V4KUP966U - SODIUM MOLYBDATE MO-99
|
|
The pertechnetate ion distributes in the body similarly to the iodide ion, but is not organified. In contrast to the iodide ion, the pertechnetate is released unchanged from the thyroid gland. Pertechnetate concentrates in the thyroid gland, salivary glands, gastric mucosa and choroid plexus. It is used in nuclear medicine in several nuclear scanning procedures. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V09FX01 | Technetium (99mTc) pertechnetate | V Various → V09 Diagnostic radiopharmaceuticals → V09F Thyroid → V09FX Various thyroid diagnostic radiopharmaceuticals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1150647 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1015341 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100116780 |
| Country: SG | Health Sciences Authority | Identifier(s): 12480P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
